1Stock1.com
Google
 
1Stock1 Home
Financial Ratios
Mutual Fund Investing Terms
Option Trading Terms 
Stock Investing Terms
Zynerba Pharmaceuticals, Inc. (ZYNE) Yearly Returns
     Year
  Beginning Price
  Ending Price
  Gain or Loss
  Percent Gain or Loss
2016
10.07
15.59
5.52
54.82%
2017
15.59
12.52
-3.07
-19.69%
2018
12.52
2.97
-9.55
-76.28%
2019
2.97
6.04
3.07
103.37%
2020
6.04
3.30
-2.74
-45.36%
2021
3.30
2.88
-0.42
-12.73%
2022
2.88
0.53
-2.35
-81.60%
2023
0.53
1.1059*
0.5759
108.66%
*In 2023, Zynerba Pharmaceuticals (ZYNE) was acquired by Harmony Biosciences (HRMY) for $1.1059 per share.
Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).
Disclaimer/Contact Us
Stock Performance Guide         
Yearly Stock Returns Index     
Back to Yearly Stock Returns Index
Articles
From
1stock1.com